STOCK TITAN
  1. Home
  2. Sec-filings
  3. FBLG
  4. [SCHEDULE 13G/A] FibroBiologics, Inc. SEC Filing

[SCHEDULE 13G/A] FibroBiologics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock FBLG logo
Fibrobiologics

NASDAQ:FBLG

FBLG Rankings

#8005 Ranked by Market Cap
N/A Ranked by Dividends

FBLG Latest News

Jul 11, 2025
FibroBiologics to Present at the Advanced Wound Care Summit USA
Jul 9, 2025
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
Jul 7, 2025
FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10
Jun 16, 2025
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing
Jun 16, 2025
FibroBiologics to Present at the BIO International Convention 2025

FBLG Latest SEC Filings

Jul 3, 2025
[8-K] FibroBiologics, Inc. Reports Material Event

FBLG Stock Data

25.90M
30.07M
23.2%
16.98%
5.62%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON